Navigation Links
Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions
Date:6/8/2009

n via a single insertion of ITCA 650.

    Fasting & Postprandial Glucose             ITCA 650 Dose Arms
                                             (continuous daily dose)
                                       10        20        40        80
                                     mcg/day   mcg/day   mcg/day   mcg/day
    Mean FPG at baseline (mg/dL)      161.2     170.5     171.8     145.1
    Mean FPG at end of treatment
     (mg/dL)                          155.6     139.4     129.8     116.3
    Change from baseline (mg/dL)       -5.6     -31.1     -42.0     -28.8
    Change in 2-hr PPG at end of
     treatment (mg/dL)                 -8.8     -32.3     -47.1     -74.6


Substantial decreases in FPG and PPG were observed throughout treatment. Decreases in FPG were evident within 24 hours of the initiation of treatment suggesting a rapid and consistent achievement of desired exenatide levels with DUROS delivery. Changes in PPG measured at days 15 and 29 also showed consistent dose-dependent reductions.

    HbA1c & Body Weight                        ITCA 650 Dose Arms
                                             (continuous daily dose)
                                       10        20        40        80
                                     mcg/day   mcg/day   mcg/day   mcg/day
    % HbA1c at baseline               7.67      7.90      7.45      7.38
    % HbA1c at end of treatment       7.15      7.28      7.00      6.80
    Change from baseline             -0.52     -0.62     -0.45     -0.58
    Mean change in weight (kg)       -0.28     -0.31     -0.93     -2.91

Although the treatment duration in the study was only 28 days, decreases in HbA1c and body weight were observed across all dose arms. The most commonly reported adverse events were nausea and vomiting which were mostly mild, transient and dose dependent.

"The results
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions
2. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
3. Prospect Therapeutics, Inc.s GCS-100 Inhibited Blood Vessel Formation in a Variety of Cancer Models
4. Cell Therapeutics, Inc. (CTI) to Present at 2009 BIO International Convention
5. Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
6. Cell Therapeutics, Inc. (CTI) to Report 2009 First Quarter Financial Results on May 7
7. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
8. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock
9. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
10. Stockholder Suits Related to TorreyPines Therapeutics, Inc. Dismissed
11. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 , ... European Society for Paediatric Endocrinology (ESPE) Meeting  ... and medical research in the field of growth  , ... Darmstadt, Germany , today announced the ... for 2014. The awards were announced during a Satellite ...
(Date:9/18/2014)... -- About POCT POCT, also ... laboratory. It helps in making fast clinical decisions, ... POCT is gaining popularity due to the increasing ... diabetes, heart disease, and obesity. It is generally ... minimize errors during the diagnosis of patients. POCT ...
(Date:9/18/2014)... DUBLIN, Ireland , September 18, ... ,Research and Markets ( http://www.researchandmarkets.com/research/czvg3s/biocompatible ) ... "Biocompatible Materials - Global Strategic ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,This report ... Materials in US$ Million by the ...
(Date:9/18/2014)... , Sept. 18, 2014 Research ... the "Global N-acetylcysteine Industry Report 2014" ... Global N-acetylcysteine Industry Report 2014 is a professional ... the global N-acetylcysteine industry. The report ... definitions, classifications, applications and industry chain structure. The ...
Breaking Biology Technology:EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3POCT Market in China 2014-2018 2Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Global N-acetylcysteine Industry Report 2014 2
... Johnson Controls , responding to increasing global demand ... a new business division to develop and service alternative ... unit will focus on geothermal, solar, biomass, wind, and ... Controls expects increased demand for these alternative forms of ...
... RedPrairie Corp. has signed a definitive agreement ... software based in Quebec City, Canada. , ,Terms of ... expected to close by the end of February. ... combined companies will operate under the RedPrairie name, and ...
... rather see - a shrinkage of one percent in the global ... question posed in Madison during a briefing on global climate change, ... cost of taking action to stabilize greenhouse gas emissions ... usual, according to British economist Lorraine Hamid. , ,The briefing was ...
Cached Biology Technology:Economist calls for an end to "business as usual" on climate change 2Economist calls for an end to "business as usual" on climate change 3
(Date:9/18/2014)... a world-leading provider of scientific, technical and medical ... Management Society (ARMS), recognized the academic research achievements ... Young Researcher of the Year Awards. , The ... Convention Centre and in conjunction with the ARMS ... Australia,s and New Zealand,s scientific community. Guest of ...
(Date:9/18/2014)... clownfish larvae can swim up to 400 kilometres in search ... with environmental change. , Clownfish spend their entire adult lives ... they must wander the open ocean, says study co-author, Dr ... Reef Studies (Coral CoE) at James Cook University. , "In ... we,ve been given a rare glimpse into how far they ...
(Date:9/17/2014)... Arts and Humanities has received a $260,000 grant from ... "The Boundaries of the Human in the Age of ... wide-ranging series of events aimed at exploring two compelling ... and researchers who are exploring the boundaries of our ... and the other involves the increasingly influential hypothesis that ...
Breaking Biology News(10 mins):Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Nemo's epic journey to find a new home 2Mellon Foundation awards grant for major project in the humanities and sciences 2
... the piano, first you have to learn notes, scales and chords ... of music. The same principle applies to speech and to reading, ... the rules of grammar. But how do separate small ... It has been shown that a specific area of the ...
... portable, wireless cameras and monitoring equipment for recording and ... who watches nature programs on TV. However, common to ... life, which becomes particularly troublesome when using such equipment ... the International Journal of Computational Science and Engineering ...
... that determine the size of plants have fascinated plant ... understood. An international research team led by plant scientists ... in the scientific journal The Plant Cell . ... from cell division to cell specialization. By extending the ...
Cached Biology News:How does the brain create sequences? 2A good tern deserves another 2Plant scientists unravel a molecular switch to stimulate leaf growth 2
PPOX Immunogen: PPOX (AAH02357, 378 a.a. ~ 478 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
Mouse monoclonal [SIT-01] to SIT ( Abpromise for all tested applications). entrezGeneID: 27240 SwissProtID: Q9Y3P8...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Biology Products: